During their session at Asembia’s AXS24, Sarah Butler and Lindsay Greenleaf of ADVI Health will examine the current status of ...

The FDA has approved fidanacogene elaparvovec-dzkt (Beqvez; Pfizer), a gene therapy administered in a one-time dose, for ...

While behavioral health care utilization has been rising, the treatment landscape has been falling. New findings show that 20 ...

Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening ...

Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) ...

The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are ...

Yael Mauer, MD, MPH, discusses the patient population who benefits most from interventions with glucagon-like peptide-1 ...

Asembia AXS24, which has record registration this year, will take place in Las Vegas, Nevada, April 28-May 2, at the Wynn & ...

UGT2B17, a metabolic enzyme known for regulating various endogenous molecules, has been identified to have heightened ...

A retrospective analysis out of Denmark could not find a causal relationship to explain trends in melanoma incidence and ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial ...